Administrative Core

行政核心

基本信息

  • 批准号:
    10598061
  • 负责人:
  • 金额:
    $ 40.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY (Administrative Core) Injury contributes to over 30 million emergency department visits annually1 and is the leading cause of death for individuals 1-44 years of age. The burden of these injuries can be reduced through injury control which includes primary prevention of injuries, optimal acute care of the injured patient and rehabilitation of the injured patient2. Yet injury control research is underfunded compared to other leading causes of death3,4 and while some COBRE active awards address basic science of traumatic brain injury, no active COBRE awards focus on injury control5. The mission of the Rhode Island Hospital Injury Control COBRE is to support the development of independent researchers to lead rigorous, innovative injury control research that changes practice and improves health. Research Project Leaders (RPL) will conduct studies utilizing two research cores (Injury Control Digital Innovation Core and Injury Control Research to Practice and Policy Core) with support from strong mentorship, leaving them well positioned to emerge as independently funded injury control research leaders. A pilot project program will support research proposals for future investigators to continue the growth of independent researchers in this important field of research. A strong mentorship program will ensure the success of current RPLs, pilot study investigators and cultivate future injury control researchers. The Administrative Core will provide the administrative, fiscal and scientific infrastructure for the research cores to assure that RPLs achieve research and career development success. This objective will be accomplished through the following specific aims: 1) Enact an organizational structure consisting of an Executive Committee, External Advisory Committee, Internal Advisory Committee and Community Advisory Board that will provide clear direction for the COBRE to succeed in meeting its mission; 2) Develop a mentoring program that supports RPLs in achieving their injury control related research and career goals and their transition to independent investigator status; 3) Implement a pilot project program that aligns with the research core objectives and identifies future RPLs and 4) Partner with an External Advisory Committee to carry out a comprehensive evaluation of all components of the RIH Injury Control COBRE. By supporting the development of junior investigators dedicated to injury control research, the COBRE will increase the number of independent injury control researchers advancing research that will tackle injury control challenges and improve population health. The establishment of this Administrative Core will provide the administrative, fiscal and scientific infrastructure necessary to successfully carryout the mission of the Rhode Island Hospital Injury Control COBRE.
项目摘要(管理核心) 每年因损伤导致超过 3000 万人次到急诊室就诊1,并且是导致死亡的主要原因 1-44 岁的个人。通过伤害控制可以减轻这些伤害的负担,其中包括 伤害的一级预防、受伤患者的最佳急性护理和受伤患者的康复2。 然而,与其他主要死亡原因相比,伤害控制研究资金不足3,4,而一些 COBRE 活跃的奖项涉及创伤性脑损伤的基础科学,没有活跃的 COBRE 奖项关注伤害控制5。 罗德岛州医院伤害控制 COBRE 的使命是支持独立的发展 研究人员领导严格、创新的伤害控制研究,改变实践并改善健康。 研究项目负责人 (RPL) 将利用两个研究核心(伤害控制数字 创新核心和伤害控制研究到实践和政策核心)在强有力的指导支持下, 使他们能够成为独立资助的伤害控制研究的领导者。试点项目 该计划将支持未来研究人员的研究提案,以继续发展独立研究 这一重要研究领域的研究人员。强有力的指导计划将确保当前的成功 RPL、试点研究调查员和培养未来的伤害控制研究人员。行政核心将 为研究核心提供行政、财政和科学基础设施,以确保 RPL 实现 研究和职业发展的成功。这一目标将通过以下具体措施来实现 目标: 1) 制定一个由执行委员会、外部咨询委员会、 内部咨询委员会和社区咨询委员会将为 COBRE 提供明确的方向 成功完成其使命; 2) 制定指导计划,支持 RPL 实现伤害目标 控制相关研究和职业目标及其向独立研究者地位的过渡; 3)实施 与研究核心目标相一致并确定未来 RPL 的试点项目计划以及 4) 合作伙伴 与外部咨询委员会一起对 RIH 损伤的所有组成部分进行全面评估 控制 COBRE。通过支持致力于伤害控制研究的初级研究人员的发展, COBRE 将增加独立伤害控制研究人员的数量,推进研究以解决 伤害控制挑战和改善人口健康。该行政核心的设立将 提供成功履行使命所需的行政、财政和科学基础设施 罗德岛医院伤害控制 COBRE。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael J Mello其他文献

Leveraging emergency care to reach key populations for 'the last mile' in HIV programming: a waiting opportunity.
利用紧急护理来覆盖艾滋病毒规划的“最后一英里”重点人群:等待的机会。
  • DOI:
    10.1097/qad.0000000000003709
  • 发表时间:
    2023-11-16
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Joshua Smith;R. Bosire;C. Farquhar;David A Katz;Joshua Kimani;S. Masyuko;Michael J Mello;A. Aluisio
  • 通讯作者:
    A. Aluisio
Reducing Alcohol Use Before and After Surgery: Qualitative Study of Two Treatment Approaches
手术前后减少饮酒:两种治疗方法的定性研究
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lyndsay Chapman;Tom Ren;Jake Solka;A. Bazzi;Brian Borsari;Michael J Mello;Anne C. Fernandez
  • 通讯作者:
    Anne C. Fernandez

Michael J Mello的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael J Mello', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10331944
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE)
罗德岛医院伤害控制卓越生物医学研究中心 (COBRE)
  • 批准号:
    10331943
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE)
罗德岛医院伤害控制卓越生物医学研究中心 (COBRE)
  • 批准号:
    10598059
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
IAMSBIRT: Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers
IAMSBIRT:在国家儿科创伤中心队列中实施酒精滥用 SBIRT
  • 批准号:
    10170926
  • 财政年份:
    2017
  • 资助金额:
    $ 40.57万
  • 项目类别:
IAMSBIRT: Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers
IAMSBIRT:在国家儿科创伤中心队列中实施酒精滥用 SBIRT
  • 批准号:
    10223170
  • 财政年份:
    2017
  • 资助金额:
    $ 40.57万
  • 项目类别:
IAMSBIRT: Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers
IAMSBIRT:在国家儿科创伤中心队列中实施酒精滥用 SBIRT
  • 批准号:
    10430304
  • 财政年份:
    2017
  • 资助金额:
    $ 40.57万
  • 项目类别:
An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use
减少受伤青少年饮酒的电子育儿技能干预
  • 批准号:
    8950496
  • 财政年份:
    2015
  • 资助金额:
    $ 40.57万
  • 项目类别:
An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use
减少受伤青少年饮酒的电子育儿技能干预
  • 批准号:
    9145612
  • 财政年份:
    2015
  • 资助金额:
    $ 40.57万
  • 项目类别:
ReDIAL: A Telephone Brief Intervention for Injured Emergency Department Patients
ReDIAL:针对急诊科受伤患者的电话简短干预
  • 批准号:
    8640067
  • 财政年份:
    2010
  • 资助金额:
    $ 40.57万
  • 项目类别:
ReDIAL: A Telephone Brief Intervention for Injured Emergency Department Patients
ReDIAL:针对急诊科受伤患者的电话简短干预
  • 批准号:
    7782172
  • 财政年份:
    2010
  • 资助金额:
    $ 40.57万
  • 项目类别:

相似海外基金

Administrative Core
行政核心
  • 批准号:
    10331944
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs
患有严重疾病的老年性和性别少数患者:建立项目以确定和满足需求
  • 批准号:
    10684915
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Translational Studies of the Short-Chain Fatty Acid Acetate for Improving Age-Associated Arterial Dysfunction
短链脂肪酸乙酸酯改善年龄相关动脉功能障碍的转化研究
  • 批准号:
    10634596
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs
患有严重疾病的老年性和性别少数患者:建立项目以确定和满足需求
  • 批准号:
    10523705
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities
青少年处方阿片类药物使用障碍导致的神经认知障碍:纵向影响、神经机制和合并症
  • 批准号:
    10599270
  • 财政年份:
    2022
  • 资助金额:
    $ 40.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了